Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2-Adrenergic and Dopamine D1 Receptors

Cited by (232)

Items 101–200 of 232

1. Dose-Response Effects of Acute Aerobic Exercise Intensity on Inhibitory Control in Children With Attention Deficit/Hyperactivity Disorder
   Yu-Jung Tsai, Shu‐Shih Hsieh, Chung‐Ju Huang, Tsung‐Min Hung · 2021 · Frontiers in Human Neuroscience
2. Differential long-term medication impact on executive function and delay aversion in ADHD
   Belén Rubio Morell, Sergio Hernández Expósito · 2017 · Applied Neuropsychology Child
3. Methylphenidate Dose-Dependently Affects Aggression and Improves Fear Extinction and Anxiety in BALB/cJ Mice
   Amanda Jager, Doranda Kanters, Femke E. Geers, Jan K. Buitelaar, Tamás Kozicz, Jeffrey Colm Glennon · 2019 · Frontiers in Psychiatry
4. Attention-Deficit/Hyperactivity Disorder
   Gyula Bokor, Peter Anderson · 2014 · Journal of Pharmacy Practice
5. Effects of the alpha‐2 adrenoceptor agonist guanfacine on attention and working memory in aged non‐human primates
   Emmanuel Decamp, Kathryn Clark, Jay S. Schneider · 2011 · European Journal of Neuroscience
6. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of Attention Deficit Hyperactivity Disorder
   Sucharita S. Somkuwar, K. Kantak, L. Dwoskin · 2015 · Journal of Neuroscience Methods
7. Catecholamine mechanisms in the prefrontal cortex: proven strategies for enhancing higher cognitive function
   C. Berridge, A. Arnsten · 2015 · Current Opinion in Behavioral Sciences
8. Dissociative effects of methylphenidate in nonhuman primates: trade-offs between cognitive and behavioral performance
   Rajala, Abigail Z., Henriques, Jeffrey B., Populin, Luis C. · 2012 · Journal of Cognitive Neuroscience
9. Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder
   Subin Park, Jae-Won Kim, Young-Hui Yang, Soon‐Beom Hong, Min-Hyeon Park, Boong‐Nyun Kim, Min‐Sup Shin, Hee‐Jeong Yoo, Soo-Churl Cho · 2012 · Behavioral and Brain Functions
10. Effect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI Studies
    Thérèse van Amelsvoort, Dennis Hernaus · 2016 · Frontiers in Psychiatry
11. Methylphenidate and the juvenile brain: Enhancement of attention at the expense of cortical plasticity?
    Kimberly R. Urban, Wen‐Jun Gao · 2013 · Medical Hypotheses
12. Differential effects of acute and chronic treatment with the α2-adrenergic agonist, lofexidine, on cocaine self-administration in rhesus monkeys
    Stephen John Kohut, Peter A. Fivel, Nancy K. Mello · 2013 · Drug and Alcohol Dependence
13. Stress Response, Brain Noradrenergic System and Cognition
    Paweł Jan Winklewski, Marek Radkowski, Magdalena Wszędybył-Winklewska, Urszula Anna Demkow · 2017 · Advances in experimental medicine and biology
14. How do stupendous cannabinoids modulate memory processing via affecting neurotransmitter systems?
    Salar Vaseghi, Mohammad Nasehi, Mohammad‐Reza Zarrindast · 2020 · Neuroscience & Biobehavioral Reviews
15. Semantic priming and neurobiology in schizophrenia: A theoretical review
    Victor Nascimento Almeida, Márcia Radanovic · 2021 · Neuropsychologia
16. Modafinil increases reward salience in a slot machine game in low and high impulsivity pathological gamblers
    Kelly A. Smart, Renée C. Desmond, Constantine X. Poulos, Martin H. Zack · 2013 · Neuropharmacology
17. Effects of methylphenidate on responses to novelty in a teleost fish (Poecilia reticulata)
    Alex R. De Serrano, Charmaine Fong, F. Helen Rodd · 2016 · Behavioural Brain Research
18. Chronic atomoxetine treatment during adolescence does not influence decision-making on a rodent gambling task, but does modulate amphetamine’s effect on impulsive action in adulthood
    Mason M. Silveira, W. Spencer Murch, Luke Clark, Catharine A. Winstanley · 2015 · Behavioural Pharmacology
19. Neural mechanisms underlying the therapeutic actions of guanfacine treatment in youth with ADHD: A pilot fMRI study
    Bédard, Anne-Claude V., Schulz, Kurt P., Krone, Beth, Pedraza, Juan, Duhoux, Stephanie, Halperin, Jeffrey M., Newcorn, Jeffrey H. · 2015 · Psychiatry Research: Neuroimaging
20. Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum
    Emmanuel Quansah, Tyra Zetterström · 2019 · Neurochemistry International
21. Paternal exposure to a common pharmaceutical (Ritalin) has transgenerational effects on the behaviour of Trinidadian guppies
    Alex R. De Serrano, Kimberly A. Hughes, F. Helen Rodd · 2021 · Scientific Reports
22. Possible contributions of a novel form of synaptic plasticity inAplysiato reward, memory, and their dysfunctions in mammalian brain
    Robert D. Hawkins · 2013 · Learning & Memory
23. Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents
    D. Connor, A. Arnsten, G. Pearson, Gabriella F Greco · 2014 · Expert Opinion on Pharmacotherapy
24. Differential effects of ADHD medications on impulsive action in the mouse 5-choice serial reaction time task
    Ciarán Martin Fitzpatrick, Jesper Tobias Andreasen · 2019 · European Journal of Pharmacology
25. Transcutaneous vagus nerve stimulation in patients with attention-deficit/hyperactivity disorder: A viable option?
    Tino Zaehle, Kerstin Krauel · 2021 · Progress in brain research
26. Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention–deficit/hyperactivity disorder, through α2-adrenoceptor activation
    Masato Umehara, Yukio Ago, Takuya Kawanai, Kazumi Fujita, Naoki Hiramatsu, Kazuhiro Takuma, Toshio Matsuda · 2013 · Behavioural Pharmacology
27. A critical examination of best dose analysis for determining cognitive-enhancing potential of drugs: studies with rhesus monkeys and computer simulations
    Paul L. Soto, Jesse Dallery, Nancy Almand Ator, Brian R Katz · 2013 · Psychopharmacology
28. The Effects of Methylphenidate (Ritalin) on the Neurophysiology of the Monkey Caudal Prefrontal Cortex
    Sébastien Tremblay, Florian Pieper, Adam J. Sachs, Ridha Joober, Julio Martínez-Trujillo · 2019 · eNeuro
29. Methylphenidate affects task-switching and neural signaling in non-human primates
    Rajala, Abigail Z, Populin, Luis C, Jenison, Rick L · 2020 · Psychopharmacology
30. Methylphenidate as a causal test of translational and basic neural coding hypotheses
    Amy M. Ni, Brittany Bowes, Douglas A. Ruff, Marlene R. Cohen · 2022 · Proceedings of the National Academy of Sciences
31. Shared and Unique Effects of Long-Term Administration of Methylphenidate and Atomoxetine on Degree Centrality in Medication-Naïve Children With Attention-Deficit/Hyperactive Disorder
    Zhao Fu, Jing Yuan, Xuyao Pei, Kangfuxi Zhang, Chenyang Xu, Na Hu, Rao Xie, Yilu Zhao, Yufeng Wang, Li Yang et al. · 2022 · The International Journal of Neuropsychopharmacology
32. The effects of methylphenidate and atomoxetine on Drosophila brain at single-cell resolution and potential drug repurposing for ADHD treatment
    Susu Qu, Xiangyu Zhou, Zhicheng Wang, Wei Yi, Han Zhou, Xinshuang Zhang, Qingjie Zhu, Yanmin Wang, Quanjun Yang, Likun Jiang et al. · 2023 · Molecular Psychiatry
33. Effects of Noradrenergic Stimulation Upon Context-Related Extinction Learning Performance and BOLD Activation in Hippocampus and Prefrontal Cortex Differ Between Participants Showing and Not Showing Renewal
    Silke Lissek, Anne Klass, Martin Tegenthoff · 2019 · Frontiers in Behavioral Neuroscience
34. Prefrontal Cortex Activation and Stopping Performance Underlie the Beneficial Effects of Atomoxetine on Response Inhibition in Healthy Volunteers and Those With Cocaine Use Disorder
    Peter Zhukovsky, Sharon Morein‐Zamir, Hisham Ziauddeen, Emilio Fernández-Egea, Chun Meng, Ralf Regenthal, Barbara Jacquelyn Sahakian, Edward Thomas Bullmore, Trevor William Robbins, Jeffrey W. Dalley et al. · 2021 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
35. Adult ADHD: it is old and new at the same time – what is it?
    Raly James Perez Custodio, Jan Georg Hengstler, Jae Hoon Cheong, Hee Jin Kim, Edmund Wascher, Stephan Getzmann · 2023 · Reviews in the Neurosciences
36. Stimulant side effects and inverted-U: Implications for ADHD guidelines
    Florence Lévy · 2012 · Australian & New Zealand Journal of Psychiatry
37. The Relationship Between Prenatal, Perinatal, and Postnatal Factors and ADHD: The Role of Nutrition, Diet, and Stress
    Lubna Al‐Gailani, Ali Al‐Kaleel · 2024 · Developmental Psychobiology
38. The effects of methylphenidate on cognitive performance of healthy male rats
    Claire L. Rostron, Elise Kaplan, Victoria Gaeta, Rachel Nigriello, Eleanor Jane Dommett · 2013 · Frontiers in Neuroscience
39. α2- and β-adrenoceptors involvement in nortriptyline modulation of auditory sustained attention and impulsivity
    Swagata Roychowdhury, Zulma Peña-Contreras, Jason Tam, Amulya Yadlapalli, Lu Dinh, Justin Nichols, Debarshi Basu, Marco Atzori · 2012 · Psychopharmacology
40. Integrative proteomics and pharmacogenomics analysis of methylphenidate treatment response
    da Silva, Bruna S., Leffa, Douglas T., Beys-da-Silva, Walter O., Torres, Iraci L. S., Rovaris, Diego L., Victor, Marcelo M., Rohde, Luis A., Mota, Nina R., Oliveira, Carla de, Berger, Markus et al. · 2019 · Translational Psychiatry
41. Association of regulatory variants of dopamine β-hydroxylase with cognition and tardive dyskinesia in schizophrenia subjects
    Toyanji Joseph Punchaichira, Anirban Mukhopadhyay, Prachi Kukshal, Triptish Bhatia A, Smita Neelkanth Deshpande, Bittianda Kuttapa Thelma · 2020 · Journal of Psychopharmacology
42. Effects of Methylphenidate on the Dopamine Transporter and Beyond
    Tyra Zetterström, Emmanuel Quansah, Martin C. Grootveld · 2022 · Current topics in behavioral neurosciences
43. Noradrenergic regulation of cue-guided decision making and impulsivity is doubly dissociable across frontal brain regions
    Chloe S. Chernoff, Tristan J. Hynes, Jackson D. Schumacher, Shrishti Ramaiah, Dimitrios K. Avramidis, Leili Mortazavi, Stan Floresco, Catharine A. Winstanley · 2023 · Psychopharmacology
44. Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer’s disease
    Ravikumar Ponnusamy, Margaret Windy McNerney, Shahrzad Moghadam, Ahmad Salehi · 2017 · Brain Research
45. The Alpha-2A Adrenergic Receptor Gene -1291C/G Single Nucleotide Polymorphism is Associated with the Efficacy of Methylphenidate in Treating Taiwanese Children and Adolescents with Attention-Deficit Hyperactivity Disorder
    Hui-Ching Huang, Lawrence Shih‐Hsin Wu, Shun-Chieh Yu, Bojian Wu, Ahai Chang Lua, Shin-Min Lee, Chao‐Zong Liu · 2018 · Psychiatry Investigation
46. Influence of Methylphenidate on the Frequency of Stuttering
    Henk Rabaeys, Henny-Annie Bijleveld, Dirk Devroey · 2015 · Annals of Pharmacotherapy
47. ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives
    Bogdańska-Chomczyk, Ewelina, Majewski, Mariusz Krzysztof, Kozłowska, Anna · 2025 · International Journal of Molecular Sciences
48. Influence of pantogam and atomoxetine on attention stability and distribution of dopamine D2 and GABAB receptors in the attention deficit mouse model
    Georgy I. Kovalev, N. A. Sukhorukova, Екатерина Валерьевна Васильева, Е. А. Кондрахин, Рамиз Меджидович Салимов · 2021 · Biomeditsinskaya Khimiya
49. No Evidence for Association Between Norepinephrine Transporter-3081 (A/T) Polymorphism and Attention Deficit Hyperactivity Disorder in Iranian Population
    Mohammad Reza Eslami Amirabadi, Rozita Davari-Ashtiani, M. Khademi, Sepideh Rajeziesfahani, B. Emamalizadeh, A. Movafagh, F. Arabgol, Said Sadr, H. Darvish, K. Razjouyan · 2015 · Iranian Red Crescent Medical Journal
50. Applications of pharmacogenetics in children with attention-deficit/hyperactivity disorder
    Florence Lévy · 2014 · Pharmacogenomics and Personalized Medicine
51. Platelet Vesicular Monoamine Transporter 2 Density in the Disruptive Behavior Disorders
    Gil Zalsman, Dorit Aslanov-Farbstein, Moshe Rehavi, Netta Roz, Robert R. J. M. Vermeiren, Nathaniel Laor, Abraham Weizman, Paz Toren · 2011 · Journal of Child and Adolescent Psychopharmacology
52. The Effects of Methylphenidate Treatment on Child Growth in Thai Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Kanchana Koonrungsesomboon, Nut Koonrungsesomboon · 2019 · Journal of Child and Adolescent Psychopharmacology
53. Prepubertal methylphenidate leads to sex-dependent differences in probabilistic discounting
    Gabrielle Kelly, Jessica C. Bezenah, Alexandra N. Tejada, Benjamin Johnson, Briana Vazquez, Melissa Espinosa, Leslie Renee Amodeo · 2022 · Pharmacology Biochemistry and Behavior
54. The impact of l-dopa on attentional impairments in a rat model of Parkinson’s disease
    Elizabeth S. Smith, Gwendolyn A. Hardy, Timothy J. Schallert, Hongjoo J. Lee · 2016 · Neuroscience
55. Single exposure of dopamine D1 antagonist prevents and D2 antagonist attenuates methylphenidate effect
    Nachum Dafny, Catherine M. Claussen, Witte LJ · 2015 · Journal of Experimental Pharmacology
56. Priming locus coeruleus noradrenergic modulation of medial perforant path-dentate gyrus synaptic plasticity
    Ramamoorthy Rajkumar, Jigna Rajesh Kumar, Gavin Stewart Dawe · 2016 · Neurobiology of Learning and Memory
57. Methylphenidate does not enhance visual working memory but benefits motivation in macaque monkeys
    Mariann Oemisch, Kevin Johnston, Martin Paré · 2016 · Neuropharmacology
58. A 24-Month Effects of Methylphenidate Use on Growth in Children and Adolescents With Attention Deficit Hyperactivity Disorder
    Yoojeong Lee, Nayeong Kong, San Koo, Dai-Seg Bai, Hee jin Kim, Hyunseok Jeong, Wan Seok Seo · 2022 · Psychiatry Investigation
59. Psychopharmacology of Neurodevelopmental Disorders in Children
    Jatinder Singh, Paramala Santosh · 2016 · Springer eBooks
60. Overlapping and differential neuropharmacological mechanisms of stimulants and nonstimulants for attention-deficit/hyperactivity disorder: A comparative neuroimaging analysis
    Pan, Nanfang, Ma, Tianyu, Liu, Yixi, Zhang, Shufang, Hu, Samantha, Shekara, Aniruddha, Cao, Hengyi, Gong, Qiyong, Chen, Ying · 2024 · Psychological Medicine
61. Dynamic Network Connectivity: from monkeys to humans
    Amy F.T. Arnsten, Min Wang, Mark D’Esposito · 2024 · Frontiers in Human Neuroscience
62. A Dopamine D1 Agonist Versus Methylphenidate in Modulating Prefrontal Cortical Working Memory
    Yang Yang, Mechelle M. Lewis, Lan Kong, Richard B. Mailman · 2022 · Journal of Pharmacology and Experimental Therapeutics
63. Consequences of Acute or Chronic Methylphenidate Exposure Using Ex Vivo Neurochemistry and In Vivo Electrophysiology in the Prefrontal Cortex and Striatum of Rats
    Mathieu Di Miceli, Asma Derf, B. Gronier · 2022 · International Journal of Molecular Sciences
64. Guanfacine inhibits interictal epileptiform events and sodium currents in prefrontal cortex pyramidal neurons
    Michał Pasierski, Weronika Kołba, Bartłomiej Szulczyk · 2023 · Pharmacological Reports
65. Blockade of α2-adrenergic receptors in prelimbic cortex: impact on cocaine self-administration in adult spontaneously hypertensive rats following adolescent atomoxetine treatment
    Britahny M. Baskin, Bríd Á. Nic Dhonnchadha, Linda P. Dwoskin, Kathleen M. Kantak · 2017 · Psychopharmacology
66. Hypothesized Mechanisms of Cognitive Impairment During High-Intensity Acute Exercise
    Myungjin Jung, Minsoo Kang, Paul Dinneen Loprinzi · 2023 · Integrated science
67. The Modulatory Effects of Atomoxetine on Aberrant Connectivity During Attentional Processing in Cocaine Use Disorder
    Liam J. Nestor, Maartje Luijten, Hisham Ziauddeen, Ralf Regenthal, Barbara Jacquelyn Sahakian, Trevor William Robbins, Karen D. Ersche · 2023 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
68. Atomoxetine prevents working memory loss in hyperactive rats, mediating plastic changes in prefrontal cortex pyramidal neurons
    Néstor I. Martínez-Torres, David González-Tapia, Nallely Vázquez-Hernández, Ignacio González‐Burgos · 2018 · Pharmacology Biochemistry and Behavior
69. Atomoxetine modulates the contribution of low-level signals during free viewing of natural images in rhesus monkeys
    Amélie J. Reynaud, Elvio Blini, Éric Koun, Emiliano Macaluso, Martine Meunier, Fadila Hadj‐Bouziane · 2020 · Neuropharmacology
70. Prefrontal corticotropin‐releasing factor neurons impair sustained attention via distal transmitter release
    Sofiya Hupalo, Robert C. Spencer, Craig W. Berridge · 2021 · European Journal of Neuroscience
71. Atomoxetine Reduces Decisional Impulsivity in Human Cocaine Addiction
    Tsen Vei Lim, Rudolf N. Cardinal, Hisham Ziauddeen, Ralf Regenthal, Barbara Jacquelyn Sahakian, Trevor William Robbins, Karen D. Ersche · 2024 · Biological Psychiatry
72. Adverse health effects and stresses on offspring due to paternal exposure to harmful substances
    Jiaqi Sun, Miaomiao Teng, Fengchang Wu, Xiaoli Zhao, Yunxia Li, Lihui Zhao, Wentian Zhao, Keng Po Lai, Kmy Leung, John Paul Giesy · 2022 · Critical Reviews in Environmental Science and Technology
73. Considering noradrenergically mediated facilitation of sensory signal processing as a component of psychostimulant-induced performance enhancement
    Rachel L. Navarra, Barry D. Waterhouse · 2018 · Brain Research
74. Autism and Dopamine
    Guy Mittleman, Charles D. Blaha · 2015 · Contemporary clinical neuroscience
75. How the Cerebellum and Prefrontal Cortex Cooperate During Trace Eyeblinking Conditioning
    Daniele Caligiore, Pierandrea Mirino · 2020 · International Journal of Neural Systems
76. Psychostimulants
    Steven R. Pliszka · 2012 · Wiley eBooks
77. Mechanisms of Short-Term and Intermediate-Term Memory in Aplysia
    Robert D. Hawkins, Igor Antonov, Iksung Jin · 2013 · Handbook of behavioral neuroscience
78. Attention deficit hyperactivity disorder
    Craig W. Berridge, David M. Devilbiss, Robert C. Spencer, Brooke E. Schmeichel, Amy F.T. Arnsten · 2012 · Cambridge University Press eBooks
79. Assessing attention and impulsivity in the variable stimulus duration and variable intertrial interval rodent continuous performance test schedules using dopamine receptor antagonists in female C57BL/6JRj mice
    L. Klem, M M Nielsen, Steinunn Gestsdóttir, SVEN FRANDSEN, S. Prichardt, Jesper Tobias Andreasen · 2023 · Psychopharmacology
80. The Neuropsychopharmacology of Stimulants: Dopamine and ADHD
    Paul E.A., A. Greg · 2012 · InTech eBooks
81. Psychostimulanzien und verwandte Substanzen bei psychisch Kranken
    Michael G. Kölch, Paul Lukas Plener, Jörg Michael Fegert · 2011 · Springer eBooks
82. Stimulant side effects: prefrontal/basal ganglia circuit control at dopamine D1/D2 receptors
    Florence Lévy, Mark R. Dadds · 2014 · Australasian Psychiatry
83. Atomoxetine modulates the relationship between perceptual abilities and response bias
    Carole Guedj, Amélie Reynaud, Elisabetta Monfardini, Roméo Salemme, Alessandro Farnè, Martine Meunier, Fadila Hadj‐Bouziane · 2019 · Psychopharmacology
84. Psicoestimulantes y potenciadores cognitivos: corteza prefrontal, catecolaminas y trastorno por déficit de atención/hiperactividad
    Craig W. Berridge, David M. Devilbiss · 2012 · Psiquiatría Biológica
85. An adolescent boy with kleptomania and attention‐deficit hyperactivity disorder treated with methylphenidate and guanfacine: A case report
    Kensuke Miyazaki, Michiko Uchiyama · 2023 · Neuropsychopharmacology Reports
86. The Treatment of Adult ADHD: Complexity at Hand
    Stefano Pallanti, Luana Salerno · 2020 · Springer eBooks
87. CONTRIBUTION OF CATECHOLAMINES TO VISUAL WORKING MEMORY IN THE MACAQUE MONKEY
    Mariann Oemisch · 2012 · QSpace (Queen's University Library)
88. Attention Deficit/Hyperactivity Disorder in Adults : Prevalence, Psychiatric Comorbidities and Long-term Outcome
    Dan Edvinsson · 2017 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
89. Methylphenidate modulates motor cortical dynamics and behavior
    Jessica R. Verhein, Saurabh Vyas, K.V. Shenoy · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
90. Ritalin
    Colzato, Lorenza S., Arntz, Fréderique E. · 2017 · Theory-Driven Approaches to Cognitive Enhancement
91. Theory of visual attention (TVA) applied to rats performing the 5-choice serial reaction time task: differential effects of dopaminergic and noradrenergic manipulations
    Mona El-Sayed Hervig, Chiara Toschi, Anders Petersen, Signe Vangkilde, Ulrik Gether, Trevor William Robbins · 2022 · Psychopharmacology
92. Atomoxetine promotes incentive value of modafinil and sensitizes exploratory behavior
    Jesús E. Yepez, Jorge Juárez · 2023 · Pharmacology Biochemistry and Behavior
93. Toward Systems Neuroscience of Shared and Distinct Neural Effects of Medications Used to Treat Attention-Deficit/Hyperactivity Disorder
    F. Xavier Castellanos, Emma G. Meyer · 2013 · Biological Psychiatry
94. DOES METHYLPHENIDATE ENHANCE COGNITION IN NORMAL RATS AND DOES IT AFFECT NEURONAL POPULATION
    Nithya Ravichandran, Sampath Madhyastha, Vrinda Mariya Elenjickal, Teresa Joy, Vandana Blossom, Mangala Manohar Pai · 2015 · International Journal of Pharmacy and Pharmaceutical Sciences
95. Catecholamine modulators: lessons from nonhuman primates
    Castellanos, F. Xavier, Kelly, Clare · 2010 · Journal of the American Academy of Child & Adolescent Psychiatry
96. Noradrenergic modulation of saccades in Parkinson’s disease
    Isabella F Orlando, Frank Hubert Hezemans, Rong Ye, Alexander G. Murley, Negin Holland, Ralf Regenthal, Roger A. Barker, Caroline H. Williams‐Gray, Luca Passamonti, Trevor William Robbins et al. · 2024 · medRxiv
97. Chapter 60. Treatment of Child and Adolescent Disorders
    Karen Wagner, Steven R. Pliszka · 2024 · American Psychiatric Association Publishing eBooks
98. Effects of Age and Atomoxetine on Olfactory Perception and Learning and Underlying Plasticity Mechanisms in Rats
    Ruhuf Abu‐Labdeh, Tamunotonye Omoluabi, Qi Yuan · 2024 · European Journal of Neuroscience
99. Methylphenidate in Borderline Personality Disorder: Assessing Its Therapeutic Potential and Limitations
    Simone Pardossi, Alessandro Cuomo, Despoina Koukouna, Mario Pinzi, Bernardo Firenzuoli, Andrea M. Fagiolini · 2025 · Life
100. Role of Methylphenidate Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Case Series
     Varchasvi Mudgal, Saloni Mishra, Umesh Datta Gupta, Koustubh R Bagul · 2025 · Cureus